Min‐Yi Chu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Min‐Yi Chu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Raymond C. K. Chan
Department of Psychiatry, School of Clinical Medicine The University of Hong Kong Hong Kong China
3 shared publications - Simon Sai Yu Lui
The University of Hong Kong
3 shared publications Eric F. C. Cheung
Castle Peak Hospital, Hong Kong, China
1 shared publicationHua Ni
Shanghai Xuhui Mental Health Centre, Shanghai, China
1 shared publicationHui‐Xin Hu
Translational Neuropsychology and Applied Cognitive Neuroscience Laboratory, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication- Hui‐Xin Hu
Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health Institute of Psychology Beijing China
1 shared publication
Latest Publications
- Open Access
- 27 December 2023
- Published by Wiley in Psych Journal
- Vol. 13 (2) , 166-175
The effect of noninvasive brain stimulation on anhedonia in patients with schizophrenia and depression: A systematic review and meta‐analysis
Anhedonia is a transdiagnostic symptom found in patients with schizophrenia and depression. Current pharmacological interventions for anhedonia are unsatisfactory in a considerable proportion of patients. There has been growing interest in applying noninvasive brain stimulation (NIBS) to patients with anhedonia. However, evidence for the efficacy of NIBS for anhedonia remain inconsistent. This study systematically identified all studies that measured anhedonia and applied NIBS in patients with schizophrenia or depression. We conducted a search using the various databases in English (PubMed, EBSCOHost (PsycInfo/PsycArticles), Web of Science) and Chinese (China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform) languages, and reviewed original research articles on NIBS published from January 1989 to July 2023. Our search had identified 15 articles for quantitative synthesis, with three concerning schizophrenia samples, 11 concerning samples with depression, and one concerning both clinical samples. We conducted a meta‐analysis based on the 15 included studies, and the results suggested that NIBS could improve anhedonia symptoms in schizophrenia patients and patients with depression, with a medium‐to‐large effect size. Our findings are preliminary, given the limited number of included studies. Future NIBS research should measure anhedonia as a primary outcome and should recruit transdiagnostic samples.
- 27 December 2023
- Published by Wiley in Psych Journal
- Vol. 13 (2) , 166-175
Open AccessThe effect of noninvasive brain stimulation on anhedonia in patients with schizophrenia and depression: A systematic review and meta‐analysis
Anhedonia is a transdiagnostic symptom found in patients with schizophrenia and depression. Current pharmacological interventions for anhedonia are unsatisfactory in a considerable proportion of patients. There has been growing interest in applying noninvasive brain stimulation (NIBS) to patients with anhedonia. However, evidence for the efficacy of NIBS for anhedonia remain inconsistent. This study systematically identified all studies that measured anhedonia and applied NIBS in patients with schizophrenia or depression. We conducted a search using the various databases in English (PubMed, EBSCOHost (PsycInfo/PsycArticles), Web of Science) and Chinese (China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform) languages, and reviewed original research articles on NIBS published from January 1989 to July 2023. Our search had identified 15 articles for quantitative synthesis, with three concerning schizophrenia samples, 11 concerning samples with depression, and one concerning both clinical samples. We conducted a meta‐analysis based on the 15 included studies, and the results suggested that NIBS could improve anhedonia symptoms in schizophrenia patients and patients with depression, with a medium‐to‐large effect size. Our findings are preliminary, given the limited number of included studies. Future NIBS research should measure anhedonia as a primary outcome and should recruit transdiagnostic samples.
- Open Access
- 31 October 2023
- Published by Wiley in Psych Journal
- Vol. 13 (1) , 145-148
Social and non‐social reward processing in subclinical depression
This study applied two incentive delay tasks involving social and non‐social incentive types to 76 pairs of participants with high and low depressive symptoms. The results suggest that higher levels of depressive symptoms are correlated with abnormalities in social and non‐social reward processing even in the healthy populations.
- 31 October 2023
- Published by Wiley in Psych Journal
- Vol. 13 (1) , 145-148
Open AccessSocial and non‐social reward processing in subclinical depression
This study applied two incentive delay tasks involving social and non‐social incentive types to 76 pairs of participants with high and low depressive symptoms. The results suggest that higher levels of depressive symptoms are correlated with abnormalities in social and non‐social reward processing even in the healthy populations.
- 22 July 2019
- Published by Wiley in Psych Journal
- Vol. 9 (1) , 77-86
Impact of long‐term institutionalization on experiential pleasure and motivation in patients with schizophrenia
Anhedonia and amotivation, the hallmarks of negative symptoms in schizophrenia, are believed to be due to “emotion–behavior decoupling,” a failure in translating pleasure experience into appropriate goal‐directed behavior. A number of studies have reported that long‐term institutionalized schizophrenia patients suffer from more severe negative symptoms than community‐dwelling patients, but few studies have investigated pleasure experience and motivational behavior in schizophrenia patients who have experienced long‐term institutionalization. In this study, we recruited 26 long‐term institutionalized schizophrenia patients, 27 community‐dwelling schizophrenia patients, and 27 healthy controls. Participants were administered two specific computer‐based tasks to assess anhedonia and amotivation. The Anticipatory and Consummatory Pleasure (ACP) Task was used to measure emotion–behavior decoupling and the Effort‐Expenditure for Rewards Task (EEfRT) was used to measure amotivation related to rewards. Findings from the ACP Task showed that compared with healthy controls, the coupling between emotion experience and motivated behavior was significantly weaker in both clinical groups, suggesting that emotion–behavior decoupling could be a stable trait in schizophrenia patients. In the EEfRT, compared with both community‐dwelling patients and healthy controls, institutionalized patients with schizophrenia failed to expend more effort to gain potential rewards even when reward probability increased. These findings further reveal the underlying mechanism of anhedonia and amotivation and their potential relationships with long‐term institutionalization in patients with schizophrenia.
- 22 July 2019
- Published by Wiley in Psych Journal
- Vol. 9 (1) , 77-86
Impact of long‐term institutionalization on experiential pleasure and motivation in patients with schizophrenia
Anhedonia and amotivation, the hallmarks of negative symptoms in schizophrenia, are believed to be due to “emotion–behavior decoupling,” a failure in translating pleasure experience into appropriate goal‐directed behavior. A number of studies have reported that long‐term institutionalized schizophrenia patients suffer from more severe negative symptoms than community‐dwelling patients, but few studies have investigated pleasure experience and motivational behavior in schizophrenia patients who have experienced long‐term institutionalization. In this study, we recruited 26 long‐term institutionalized schizophrenia patients, 27 community‐dwelling schizophrenia patients, and 27 healthy controls. Participants were administered two specific computer‐based tasks to assess anhedonia and amotivation. The Anticipatory and Consummatory Pleasure (ACP) Task was used to measure emotion–behavior decoupling and the Effort‐Expenditure for Rewards Task (EEfRT) was used to measure amotivation related to rewards. Findings from the ACP Task showed that compared with healthy controls, the coupling between emotion experience and motivated behavior was significantly weaker in both clinical groups, suggesting that emotion–behavior decoupling could be a stable trait in schizophrenia patients. In the EEfRT, compared with both community‐dwelling patients and healthy controls, institutionalized patients with schizophrenia failed to expend more effort to gain potential rewards even when reward probability increased. These findings further reveal the underlying mechanism of anhedonia and amotivation and their potential relationships with long‐term institutionalization in patients with schizophrenia.